| 1 |
2024 |
Zhengyan Zhang, Yingying Tang, Yu Wang, Junyi Xu, Xiaotong Yang, Mingzhu Liu, Massimiliano Mazzone, Ningning Niu, Yongwei Sun, Yujie Tang, Jing Xue. SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer, Advanced Science. 2024; 11: 2402244.
https://doi.org/10.1002/advs.202402244 |
| 2 |
2025 |
Jeong Woon Jang, Min Ji Kim, Chang Sik Cho, Jun Hee Han, Sangsu Bae, Hongjun Jeon, Dong Hyun Jo, Hye Jin Nam. Optimizing HDAC inhibitors to enhance HDR-associated CRISPR-Cas9 gene editing efficiency in vivo and in vitro, Heliyon. 2025; 11: e42971e42971.
https://doi.org/10.1016/j.heliyon.2025.e42971 |
| 3 |
2025 |
Daniel Stopper, Irina Honin, Felix Feller, Finn K. Hansen. Development of Ethyl-Hydrazide-Based Selective Histone Deacetylase 6 (HDAC6) PROTACs, ACS Medicinal Chemistry Letters. 2025; acsmedchemlett.5c00033.
https://doi.org/10.1021/acsmedchemlett.5c00033 |
| 4 |
2024 |
Samima Khatun, Sk. Abdul Amin, Debasmita Choudhury, Boby Chowdhury, Tarun Jha, Shovanlal Gayen. Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents, Expert Opinion on Drug Discovery. 2024; 19: 353.
https://doi.org/10.1080/17460441.2024.2305730 |
| 5 |
2024 |
Mohammad-Salar Hosseini, Zohreh Sanaat, Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Mahsa Akbarzadeh. Histone deacetylase inhibitors for leukemia treatment: current status and future directions, European Journal of Medical Research. 2024; 29: 514.
https://doi.org/10.1186/s40001-024-02108-8 |
